From pharmacotherapy to pathophysiology: Emerging mechanisms of apolipoprotein D in psychiatric disorders

Current Molecular Medicine

Volumn 3, Issue 5, 2003, Pages 408-418

  Thomas, E A ^a,b   Copolov, D L ^a,b   Sutcliffe, J G ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOLIPOPROTEIN D; ARACHIDONIC ACID; ATYPICAL ANTIPSYCHOTIC AGENT; BIOLOGICAL MARKER; CELL NUCLEUS RECEPTOR; CHLORPROMAZINE; CLOZAPINE; DOCOSAHEXAENOIC ACID; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FATTY ACID; FLUPHENAZINE; HALOPERIDOL; ICOSAPENTAENOIC ACID; KETANSERIN; LIPID; LIPOCALIN; NEUROLEPTIC AGENT; NEUROTENSIN; NEUROTRANSMITTER RECEPTOR; OLANZAPINE; PREPROENKEPHALIN; PREPROTACHYKININ; RISPERIDONE; RNA; THIORIDAZINE; TRIFLUOPERAZINE; UNINDEXED DRUG;

ARACHIDONIC ACID METABOLISM; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; EXTRAPYRAMIDAL SYMPTOM; GENE EXPRESSION REGULATION; HUMAN; MENTAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHOLIPID MEMBRANE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; PSYCHOPHARMACOTHERAPY; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION;

ANTIPSYCHOTIC AGENTS; APOLIPOPROTEINS; APOLIPOPROTEINS D; BRAIN; CHROMOSOME MAPPING; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; MENTAL DISORDERS; POLYMORPHISM, GENETIC;

EID: 0042061195     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566524033479681     Document Type: Review

References (122)

1. Horrobin, D. F. and Bennet, C. N. (1999) Prostaglandins Leukotrienes and Essential Fatty acids, 60, 141-167.
2. Thomas, E. A. and Sutcliffe, J. G. (2002) Mol. Neurobiol., 26, 369-388.
3. Xu, S. and Venge, P. (2000) Biochim. Biophys. Acta, 18, 1-2.
4. Iacobuzio-Donahue, C. A., Ryu, B., Hruban, R. H. and Kern, S. E. (2002) Am. J. Pathol., 160, 91-99.
5. Rojo, J. V., Gonzalez, L. O., Lamelas, M. L., Merino, A. and Vizoso, F. (2001) Acta Obstet. Gynecol. Scand., 80, 158-161.
6. Sufi, P. A. and Bradpiece, H. A. (2000) Br. J. Surg., 87, 522.
7. Vazquez, J., Gonzalez, L., Merino, A. and Vizoso, F. (2000) Gynecol. Oncol., 76, 340-347.
8. McConathy, W. J. and Alaupovic, P. (1973) Fedn. Eur. Biochem. Socs. Lett., 37, 178-182.
9. Oram, J. F. and Yokoyama, S. (1996) J. Lipid Res., 37, 2473-2491.
10. Tall, A. R. (1998) Eur. Heart J., 19, A31-A35.
11. Boyles, J. K., Notterpek, L. M., Wardell, M. R. and Ball, S. C. J. (1990) J. Lipid Res., 31, 2243-2256.
12. Drayna, D., Fielding, C., McLean, J., Baer, B., Castro, G., Chen, E., Comstock, L., Henzel, W., Kohr, W., Rhee, L., Wion, K. and Lawn, R. (1986) J. Biol. Chem., 261, 16535-16539.
13. Navarro, A., Tolivia, J., Astudillo, A. and Del Valle, E. (1995) Neurosci. Lett., 254, 17-20.
14. Provost, P. R., Villeneuve, L., Weech, P. K., Milne, R. W., Marcel, Y. L. and Rassart, E. (1991) J. Lipid Res., 32, 1959-1970.
15. Patel, S. C., Asotra, K., Patel, Y. C., McConathy, W. J., Patel, R. C. and Suresh, S. (1995) Neuroreport, 6, 653-657.
16. Thomas, E. A., Danielson, P. E., Nelson, P. A., Pribyl, T. M., Hilbush, B. S., Hasel, K. W. and Sutcliffe, J. G. (2001) J. Neurochem., 76, 789-796.
17. Balbin, M., Freije, J. M. P., Fueyo, A., Sanchez, L. M. and Lopez-Otin, C. (1990) Biochem. J., 271, 803-807.
18. Dilley, W. G., Haagensen, D. E., Cox, C. E. and Wells, S. A. (1990) Breast Cancer Res. Treat, 16, 253-260.
19. Lea, O. A. (1988) Steroids, 52, 337-338.
20. Pearlman, W. H., Gueriguian, J. L. and Sawyer, M. E. (1973) J. Biol. Chem., 248, 5736-5741.
21. Peitsch, M. C. and Boguski, M. S. (1990) New Biol., 2, 197-206.
22. Zeng, C., Spielman, A. I., Vowels, B. R., Leyden, J. J., Biemann, K. and Preti, G. (1996) Proc. Natl. Acad. Sci. USA, 93, 6626-6630.
23. Morais-Cabral, J. H., Atkins, G. L., Sanchez, L. M., Lopez-Boado, Y. S., Lopez-Otin, C. and Sawyer, L. (1995) FEBS Lett., 366, 53-56.
24. Vogt, M. and Skerra, A. (2001) J. Mol. Recognit., 14, 79-86.
25. Vijayaraghavan, S., Hitman, G. A. and Kopelman, P. G. (1994) J. Clin. Endocrinol. Metab., 79, 568-570.
26. Baker, W. A., Hitman, G. A., Hawrami, K., McCarthy, M. I., Riikonen, A., Tuomilehto-Wolf, E., Nissinen, A., Tuomilehto, J., Mohan, V. and Viswanathan, M. (1994) Diabet. Med., 11, 947-952.
27. Liu, Z., Chang, G. Q. and Leibowitz, S. F. (2001) FASEB J., 15, 1329-1331.
28. Franz, G., Reindl, M., Patel, S. C., Beer, R., Unterrichter, I., Berger, T., Schmutzhard, E., Poewe, W. and Kampfl, A. (1999) J. Neurochem., 73, 1615-1625.
29. Ong, W. Y., He, Y., Suresh, S. and Patel, S. C. (1997) Neurosci., 79, 359-367.
30. Terrisse, L., Sequin, D., Bertrand, P., Poirier, J., Milne, R. and Rassart, E. (1999) Brain Res. Mol. Brain Res., 70, 26-35.
31. Suresh, S., Yan, Z., Patel, R. C., Patel, Y. C. and Patel, S. C. (1998) J. Neurochem., 70, 242-251.
32. Yoshida, K., Cleaveland, E. S., Nagle, J. W., French, S., Yaswen, L., Ohshima, T., Brady, R. O., Pentchev, P.g. and Kulkarni, A. B. (1996) DNA Cell Biol., 15, 873-882.
33. Boyles, J. K., Notterpek, L. M. and Anderson, L. J. (1990) J. Biol. Chem., 265, 17805-17815.
34. Thomas, E. A., Laws, S., Sutcliffe, J. G., Harper, C., Dean, B., McClean, C., Masters, C., Lautenschlager, N., Gandy, S. E. and Martins, R. N. (2003) Biological Psychiatry, in press.
35. Belloir, B., Kovari, E., Surini-Demiri, M. and Savioz, A. (2001) J. Neurosci. Res., 64, 61-69.
36. Kalman, J., McConathy, W., Araoz, C., Kasa, P. and Lacko, A. (2000) Neurol. Res., 22, 330-336.
37. Terrisse, L., Poirier, J., Bertrand, P., Merched, A., Visvikis, S., Siest, G., Milne, R. and Rassart, E. (1998) J. Neurochem., 71, 1643-1650.
38. Thomas, E. A., Sautkulis, L. N., Criado, J. R., Games, D. and Sutcliffe, J. G. (2001) J. Neurochem., 79, 1059-1064.
39. Reindl, M., Knipping, G., Wicher, I., Dilitz, E., Egg, R., Deisenhammer, F. and Berger, T. (2001) J. Neuroimmunol., 119, 327-332.
40. Harrison, P. J. and Owen, M. J. (2003) Lancet, 361, 417-419.
41. Tsuang, M. T., Gilbertson, M. W. and Faraone, S. V. (1991) Schizophr. Res., 4, 157-171.
42. Sawa, A. and Snyder, S. H. (2002) Science, 296, 692-695.
43. Badenhop, R. F., Moses, M. J., Scimone, A., Mitchell, P. B., Ewen-White, K. R., Rosso, A., Donald, J. A., Adams, L. J. and Schofield, P. R. (2002) Mol. Psychiatry., 7, 851-859.
44. Bailer, U., Leisch, F., Meszaros, K., Lenzinger, E., Willinger, U., Strobl, R., Heiden, A., Gebhardt, C., Doge, E., Fuchs, K., Sieghart, W., Kasper, S. Hornik, K. and Aschauer, H. N. (2002) Biol. Psychiatry, 52, 40-52.
45. Camp, N. J., Neuhausen, S. L., Tiobech, J., Polloi, A., Coon, H. and Myles-Worsley, M. (2001) Am. J. Hum. Genet., 69, 1278-1289.
46. Kerwin, R. and Taylor, D. (1996) CNS Drugs, 6, 71-82.
47. Ciapparelli, A., Dell'Osso, L., Pini, S., Chiavacci, M. C., Fenzi, M. and Cassano, G. B. (2000) J. Clin. Psychiatry, 61, 329-334.
48. Jann, M. W. (1991) Pharmacotherapy, 11, 179-195.
49. Fibiger, H. C. (1994) J. Clin. Psychiatry, 55, 33-36.
50. Hughes, P. and Dragunow, M. (1995) Pharmacological. Reviews, 47, 133-178.
51. MacGibbon, G. A., Lawlor, P. A., Bravo, R. and Dragunow, M. (1994) Molecular Brain Research, 23, 21-32.
52. Miller, J. (1990) J. Neurochem., 54, 1453-1455.
53. Rogue, P. and Vincedon, G. (1992) Brain Research Bulletin, 29, 469-472.
54. Marcus, M. M., Nomikos, G. G., Malmerfelt, A., Zachrisson, O., Lindefors, N. and Svensson, T. H. (1997) Brain Res. Mol. Brain Res., 45, 275-282.
55. Merchant, K. M., Dobie, D. J., Filloux, F. M., Totzke, M., Aravagiri, M. and Dorsa, D. M. (1994) J. Pharmacol. Exp. Ther., 271, 460-471.
56. Angulo, J. A., Cadet, J. L. and McEwen, B. S. (1990) Neurosci. Lett., 113, 217-221.
57. Petrack, B., Emmett, M. R., Rao, T. S., Kim, H. S. and Wood, P. L. (1990) Life Sci, 46, 687-691.
58. Langlois, M. C., Beaudry, G., Zekki, H., Rouillard, C. and Levesque, D. (2001) Neuroscience, 106, 117-128.
59. Eastwood, S. L., Heffernan, J. and Harrison, P. J. (1997) Mol. Psychiatry, 2, 322-329.
60. Schneider, J. S., Wade, T. and Lidsky, T. I. (1998) Neuroreport, 9, 133-136.
61. Toyoda, H., Takahata, R., Inayama, Y., Sakai, J., Matsumura, H., Yoneda, H., Asaba, H. and Sakai, T. (1997) Neurochem Res, 22, 249-252.
62. Riva, M. A., Tascedda, F., Lovati, E. and Racagni, G. (1997) Brain Res. Mol. Brain Res., 50, 136-142.
63. Fitzgerald, L. W., Deutch, A. Y., Gasic, G., Heinemann, S. F. and Nestler, E. J. (1995) J. Neurosci., 15, 2453-2461.
64. Chong, V. Z., Young, L. T. and Mishra, R. K. (2002) J. Neurochem., 82, 1533-1539.
65. Kontkanen, O., Toronen, P., Lakso, M., Wong, G. and Castren, E. (2002) J. Neurochem., 83, 1043-1053.
66. Sutcliffe, J. G., Foye, P. E., Erlander, M. G., Hilbush, B. S., Bodzin, L. J., Durham, J. T. and Hasel, K. W. (2000) Proc. Natl. Acad. Sci. USA, 97, 1976-1981.
67. Khan, M. M., Parikh, V. V. and Mahadik, S. P. (2002) Biol. Psychiatry, 51, 168S.
68. Khan, M. M., Parikh, V. V. and Mahadik, S. P. (2003) J. Neurochem., in press.
69. Mahadik, S. P., Khan, M. M., Evans, D. R. and Parikh, V. V. (2002) Schizophr. Res., 58, 55-62.
70. Goldman-Rakic, P. S. and Seleman, L. D. (1997) Schizophrenia Bulletin, 23, 437-458.
71. Thomas, E. A., Dean, B., Pavey, G. and Sutcliffe, J. G. (2001) Proc. Natl. Acad. Sci. USA, 98, 4066-4071.
72. Thomas, E. A., Dean, B., Scarr, E., Copolov, D. and Sutcliffe, J. G. (2003) Mol. Psychiatry, 8, 167-175.
73. Carter, C. S., Perlstein, W., Ganguli, R., Brar, J., Mintun, M. and Cohen, J. D. (1998) Am. J. Psychiatry, 155, 1285-1287.
74. Franzen, G. and Ingvar, D. H. (1975) J. Neurol. Neurosurg. Psychiatry, 38, 1027-1032.
75. Liddle, P. F., Friston, K. J., Frith, C. D., Hirsch, S. R., Jones, T. and Frackowiak, R. S. (1992) Br. J. Psychiatry, 160, 179-186.
76. Liddle, P. F. and Morris, D. L. (1991) Br. J. Psychiatry, 158, 340-345.
77. Ragland, J. D., Gur, R. C., Glahn, D. C., Censits, D. M., Smith, R. J., Lazarev, M. G., Alavi, A. and Gur, R. E. (1998) Neuropsychology, 12, 399-413.
78. Weinberger, D. R., Berman, K. F. and Zec, R. F. (1986) Arch. Gen. Psychiatry, 43, 114-134.
79. Blumberg, H. P., Stern, E., Ricketts, S., Martinez, D., de Asis, J., White, T., Epstein, J., Isenberg, N., McBride, P. A., Kemperman, I., Emmerich, S., Dhawan, V., Eiderlberg, D., Kocsis, J. H. and Silbersweig, D. A. (1999) Am. J. Psychiatry, 156, 1986-1988.
80. Drevets, W. C., Ongur, D. and Price, J. L. (1998) Mol. Psychiatry, 3, 220-226.
81. Knable, M. B. (1999) Schizophr. Res., 39, 149-152.
82. Baare, W. F., Hulshoff Pol, H. E., Hijman, R., Mali, W. P., Viergever, M. A. and Kahn, R. S. (1999) Biol. Psychiatry, 45, 1597-1605.
83. Crespo-Facorro, B., Kim, J., Andreasen, N. C., O'Leary, D. S. and Magnotta, V. (2000) Biol. Psychiatry, 48, 110-119.
84. Freedman, M., Black, S., Ebert, P. and Binns, M. (1998) Cereb. Cortex, 8, 18-27.
85. Harrison, P. J. (1999) Brain, 122, 593-624.
86. Buchsbaum, M. S., Someya, T., Teng, C. Y., Abel, L., Chin, S., Najafi, A., Haier, R. J., Wu, J. and Bunney, W. E. Jr. (1996) Am. J. Psychiatry, 153, 191-199.
87. Andreasen, N. C., Flashman, L., Flaum, M., Arndt, S., Swayze, V. n., O'Leary, D. S., Ehrhardt, J. C. and Yuh, W. T. (1994) JAMA, 272, 1763-1769.
88. Thune, J. J. and Pakkenberg, B. (2000) Brain Res. Brain Res. Rev., 31, 200-204.
89. Demisch, L., Heinz, K., Gerbaldo, H. and Kirsten, R. (1992) Prostaglandins Leukot Essent Fatty Acids, 46, 47-52.
90. Glen, A. I., Glen, E. M., Horrobin, D. F., Vaddadi, K. S., Spellman, M., Morse-Fisher, N., Ellis, K. and Skinner, F. S. (1994) Schizophr. Res., 12, 53-61.
91. Mahadik, S. P., Mukherjee, S., Correnti, E. E., Kelkar, H. S., Wakade, C. G., Costa, R. M. and Scheffer, R. (1994) Schizophrenia Res., 13, 239-247.
92. Mahadik, S. P., Mukherjee, S., Horrobin, D. F., Jenkins, K., Correnti, E. E. and Scheffer, R. (1996) Psychiatry Res., 63, 133-142.
93. Peet, M., Laugharne, J. D., Mellor, J. and Ramchand, C. N. (1996) Prostaglandins Leukot Essent Fatty Acids, 55, 71-75.
94. Yao, J. K., van Kammen, D. P. and Gurklis, J. A. (1996) Psychiatry Res., 60, 11-21.
95. Yao, J. K., Leonard, S. and Reddy, R. D. (2000) Schizophr. Res., 42, 7-17.
96. Puri, B. K., Hirsch, S. R., Easton, T. and Richardson, A. J. (2002) Prog Neuropsychopharmacol Biol. Psychiatry, 26, 49-52.
97. Shah, S. H., Vankar, G. K., Peet, M. and Ramchand, C. N. (2000) Schizophr. Res., 43, 163-164.
98. Ward, P. E., Sutherland, J., Glen, E. M. and Glen, A. I. (1998) Schizophr. Res., 29, 269-274.
99. Dennis, E. A. (1997) Trends Biochem. Sci., 22, 11-2.
100. Gattaz, W. F., Kollisch, M., Thuren, T., Virtanen, J. A. and Kinnunen, P. K. J. (1987) Biol. Psychiatry, 22, 421-426.
101. Ross, B. M., Hudson, C., Erlich, J., Warsh, J. J. and Kish, S. J. (1997) Arch. Gen. Psychiatry, 54, 487-494.
102. Ross, B. M., Turenne, S., Moszczynska, A., Warsh, J. J. and Kish, S. J. (1999) Brain Research, 821, 407-413.
103. Balsinde, J., Bianco, I. D., Ackermann, E. J., Conde-Frieboes, K. and Dennie, E. A. (1995) Proc. Natl. Acad. Sci. USA, 92, 8527-8531.
104. Ishigooka, J., Shizu, Y., Wakatabe, H., Tanaka, K. and Miura, S. (1985) Biol. Psychiatry, 20, 866-873.
105. Horrobin, D. F., Glen, A. I. M. and Cantrill, R. C. (1997) Schizophr. Res., 24, 214.
106. Holmsen, H., Daniel, J. L., Dangelmaier, C. A., Molish, I., Rigmaiden, M. and Smith, J. B. (1984) Thromb. Res., 36, 419-428.
107. Peet, M. and Horrobin, D. F. (2002) J. Psychiatr. Res., 36, 7-18.
108. Horrobin, D. F., Jenkins, K., Bennett, C. N. and Christie, W. W. (2002) Prostaglandins Leukot Essent Fatty Acids, 66, 83-90.
109. Richardson, A. J., Easton, T. and Puri, B. K. (2000) Eur. Neuropsychopharmacol., 10, 189-193.
110. Fenton, W. S., Dickerson, F., Boronow, J., Hibbeln, J. R. and Knable, M. (2001) Am. J. Psychiatry, 158, 2071-4.
111. Thomas, E. A., George, R. C. and Sutcliffe, J. G. (2003) Prostaglandins, Leukotrienes and Essential Fatty Acids, in press.
112. Lin, A., Kenis, G., Bignotti, S., Tura, G. J., De Jong, R., Bosmans, E., Pioli, R., et al. (1998) Schizophr. Res., 32, 9-15.
113. Bhattacharya, S. K. and Rao, P. J. (1987) J. Pharm. Pharmacol., 39, 743-5.
114. Ono, N., Abiru, T., Sugiyama, K. and Kamiya, H. (1992) Prostaglandins Leukot Essent Fatty Acids, 46, 59-63.
115. Yao, J. K., Reddy, R. D. and van Kammen, D. P. (2001) CNS Drugs, 15, 287-310.
116. Yao, J. K., Reddy, R. D. and van Kammen, D. P. (1999) Biol. Psych., 45, 1512-1515.
117. Herken, H., Uz, E., Ozyurt, H., Sogut, S. Virit, O. and Akyol, O. (2001) Mol. Psych., 6, 66-73.
118. Deutsch, S. I., Rosse, R. B., Schwartz, B. L. and Mastropaolo, J. (2001) Clin. Neuropharmacol., 24, 43-9.
119. Do, K. Q., Trabesinger, A. H., Kirsten-Kruger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P. and Cuenod, M. (2000) Eur. J. Neurosci., 12, 3721-8.
120. Lechner, M., Wojnar, P. and Redl, B. (2001) Biochem. J., 356, 129-35.
121. Simonian, N. A. and Coyle, J. T. (1996) Annu. Rev. Pharmacol. Toxicol., 36, 83-106.
122. Horrobin, D. F. (1998) Schizophr. Res., 30, 193-208.